Clinical trial of specific imaging of infections

Nuclear Medicine Communications

Volumn 31, Issue 8, 2010, Pages 726-733

  De Murphy, Consuelo Arteaga ^a   Gemmel, Filip ^b   Balter, Jenny ^c  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

^c UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

clinical trial; imaging infection; scintigraphy; technetium; UBI 29 41

Indexed keywords

PEPTIDE DERIVATIVE; TECHNETIUM 99M; UBI [29-41]; UBI [29-41] TC 99M; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; TECHNETIUM 99M UBIQUICIDIN(29-41); TECHNETIUM COMPLEX;

ACCURACY; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TOLERABILITY; FEMALE; HUMAN; INFECTION; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; PROSTHESIS INFECTION; PYREXIA IDIOPATHICA; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BACTERIAL INFECTIONS; CHILD; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; QUALITY CONTROL; RADIOMETRY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PEPTIDE FRAGMENTS; QUALITY CONTROL; RADIOMETRY; YOUNG ADULT;

EID: 77954243816     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833a3d7f     Document Type: Article

References (20)

1. Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med 2009; 39:11-26.
2. Auler MA, Bagg S, Gordon L. The role of nuclear medicine in imaging infection. Seminin Roentgenol 2007; 42:117-121.
3. Nibbering PH, Welling MM, Van den Broek PJ, Van Wyngaarden KE, Pauwels EKJ, Calame W. Radiolabelled antimicrobial peptides for imaging of infections: a review. Nucl Med Commun 1998; 19:1117-1121.
4. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EKJ, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000; 27:292-301.
5. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. Tc-99m-Labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001; 42:788-794.
6. Nibbering PH, Welling MM, Paulusma-Annema A, Brouwer CPJM, Lupetti A, Pauwels EKJ. Tc-99m-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 2004; 45:321-326.
7. Brouwer CPJM, Bogaards SJP, Wulferink M, Velders MP, Welling MM. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice. Peptides 2006; 27:2585-2591.
8. Ferro-Flores G, de Murphy CA, Pedraza-Lopez M, Melendez-Alafort L, Zhang YM, Rusckowski M, et al. In vitro and in vivo assessment of Tc-99m-UBI specificity for bacteria. Nucl Med Biol 2003; 30:597-603.
9. Ferro-Flores G, de Murphy CA, Palomares-Rodriguez P, Melendez-Alafort L, Pedraza-Lopez M. Kit for instant Tc-99m labeling of the antimicrobial peptide ubiquicidin 29-41. J Radioanal Nucl Chem 2005; 266:307-311.
10. Welling MM, Korsak A, Gorska B, Oliver P, Mikolajczak R, Balter HS, et al. Kit with technetium-99m labelled antimicrobial peptide UBI 29-41 for specific infection detection. J Label Comp Radiopharm 2005; 48:683-691.
11. Brouwer CPJM, Sarda-Mantel L, Meulemans A, Le Guludec D, Welling MM. The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging. Mini-Rev Med Chem 2008; 8:1039-1052.
12. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide Tc-99m-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med 2005; 46:567-573.
13. Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, De Murphy CA, Herrera-Rodriguez R, Mitsoura E, et al. Biokinetics of Tc-99m-UBI 29-41 in humans. Nucl Med Biol 2004; 31:373-379.
14. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Goudarzi M, Mirfallah SH, et al. Clinical evaluation of antimicrobial peptide [Tc-99m/Tricine/HYNIC0] ubiquicidin 29-41 as a human-specific infection imaging agent. Nucl Med Biol 2009; 36:199-205.
15. Jonsson L, Ljungberg M, Strand SE. Evaluation of accuracy in activity calculations for the conjugate view method from Monte Carlo simulated scintillation camera images using experimental data in an anthropomorphic phantom. J Nucl Med 2005; 46:1679-1686.
16. 99mTc-U B-Rfis1 29-41 based on experimental and semiempirical results. Appl Radiat Isot 2004; 61:1261-1268.
17. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415:389-395.
18. 99mTc-labeled ubiquicidin 29-41 antimicrobial peptide for the scintigraphic detection of mediastinitis after cardiac surgery. Arch Med Res 2008; 39:768-774.
19. Becker W. The Contribution of Nuclear-Medicine to the Patient with Infection. Eur J Nucl Med 1995; 22:1195-1211.
20. 99mTc-UBI 29-41 for infection diagnosis: kit formulation and preliminar clinical study. Trends Radiopharm (ISTR-2005) 2007; 1:43-51.